Cipla is aiming for 40-50 global product filings in three years, says MD Achin GuptaCipla is charting its next growth phase with a strong focus on innovation, complex generics, and biosimilars. The company plans significant...
29 May, 2026, 05.30 AM IST
Innovation, biosimilars, complex generics to drive Cipla's growth: Achin Gupta, MD & Group CEOAs Cipla approaches its centenary, the company is redefining its strategy by prioritizing innovation to amplify revenues. With ambitions to...
29 May, 2026, 12.57 AM IST
Singapore recommends adults to test for HIV once in lifetimeSingapore now advises all adults aged 21 and above to get tested for HIV once in their lifetime. This comes after a rise in infections last...
23 May, 2026, 05.53 PM IST
Quote of the Day by Princess Diana: “Nothing brings me more happiness than trying to help the most vulnerable people in society. It is a goal and an essential part of my life—a kind of destiny. Whoever is in distress can call on me. I will come running wherever they are.”Quote of the Day: Princess Diana's enduring legacy is defined by her profound compassion and willingness to connect with the most vulnerabl...
19 May, 2026, 05.43 PM IST
Quote of the day by George Michael: 'Change is a stranger you have yet to know.' Life lessons on human nature, success and hardships by British singer and songwriterQuote of the day by George Michael explores the meaning of change through the words “Change is a stranger you have yet to know.” The articl...
19 May, 2026, 01.42 AM IST
Quote of the day by George Michael: 'Only time will set you free...' Life lessons on peace, success and human nature by legendary British singer and songwriterQuote of the day by George Michael highlights the words “Only time will set you free, just like me.” The quote connects with life lessons o...
13 May, 2026, 11.20 AM IST
Lord’s Mark among few global players to win HIV self-test approval, exports from June 2026Lord's Mark Industries Ltd. has secured Central Licensing Authority approval for its LordsMed HIV 1&2 Self Test, becoming one of nine globa...
01 May, 2026, 06.42 PM IST
Aurobindo to produce, supply long acting HIV treatment drugAurobindo Pharma will manufacture and supply long-acting injectable HIV treatment, cabotegravir, across 133 countries through a voluntary l...
15 Jul, 2025, 02.47 PM IST
Lupin gets USFDA nod for generic HIV drugLupin has received tentative approval from the USFDA to market a generic HIV drug in the US under PEPFAR. The drug, made at Lupin's Nagpur ...
24 Jan, 2025, 03.13 PM IST
Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...
25 Jun, 2021, 10.26 PM IST
Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...
07 Jun, 2021, 03.54 PM IST
Lupin launches generic HIV drug in US marketThe company had earlier received approval from the United States Food and Drug Administration for Abacavir and Lamivudine tablets 600 mg/30...
29 Mar, 2017, 02.23 PM IST
A biosensor to peer into insides of HIV-infected cellThis technology can offer insights which can help in controlling the AIDS infection besides insight on the interactions between HIV-1 and T...
14 Dec, 2014, 12.37 PM IST
Proteins that inhibit HIV, Ebola release identifiedResearchers have found that the same protein possesses a unique ability to block the release of HIV-1 and Ebola virus.
26 Aug, 2014, 01.59 PM IST
Effective HIV vaccine comes closer to realityThe new findings point the way towards a potentially more effective vaccine that would generate V1V2-directed HIV neutralising antibodies.
03 Mar, 2014, 01.04 PM IST
Lupin gets USFDA nod to market HIV drug in the US marketThe company's product is indicated in combination with other antiretrovirals or alone for the treatment of HIV-1 infection, it added.
10 Dec, 2013, 06.51 PM IST
New aggressive HIV strain leads to faster AIDS developmentResearchers found that the period from infection to development of AIDS was the shortest reported among HIV-1 types, at around five years.
28 Nov, 2013, 01.57 PM IST